期刊文献+

定点突变巴曲酶在毕赤酵母中的克隆与表达 被引量:5

Cloning and Expression of mutant Batroxobin,a Thrombin-like Enzyme,in Pichia pastoris by Overlap Extension PCR
下载PDF
导出
摘要 目的为避免毕赤酵母分泌的Kex2蛋白酶对发酵液中所表达的巴曲酶的降解。利用重叠PCR方法对巴曲酶基因进行定点突变,将巴曲酶基因第45位的Arg突变为Lys。方法将突变后的基因克隆到酵母分泌型表达载体pPICZαA中,将重组载体酶切线性化后经电转化转入巴斯德毕赤酵母细胞,筛选鉴定转化子,经摇瓶发酵甲醇诱导,酵母菌分泌表达有凝血活性的定点突变巴曲酶,经SDS-PAG电泳、免疫印迹确定其分子量为32 kD。结果发酵罐的表达量达到52 KU/ml发酵液,较重组天然巴曲酶的表达量提高了73.3%。结论定点突变巴曲酶的表达量比重组天然巴曲酶的表达量有显著提高,表达的突变巴曲酶同样具有凝血活性。 Objective In order to avoid secreted batroxobin expressed in p. pichia X-33 being hydrolysis by Kex2 protease,the gene of batroxobin,a thrombin-like enzyme of bathrops atrox moojeni venom, was site-directed mutated by overlap extension of PCR. The arginine residues at positions 45 of the protein product are replaced by basic amino acid residues Lys, which is Kex2 protease site. Methods The mutant gene of batroxobin was cloned into expression vector pPICZaA and transfered into Pichia pastoris X-33. The recombinant mutant batroxobin was separated and purified from fermentation liquid, showing immunological and enzyme activity by western-blotting analysis and fibrinogen-clotting assay respectively. The molecular weight is about 32.0 kD by SDS-PAGE analysis. Results The production of mutant recombinant batroxobin could achieve 52 KU/ml fermentation liquide by fermentor, the yield rise by 73.3% compared with recombinant batroxobin. Conclusion Compared with recombinant batroxobin,the production of site-directed mutant batroxobin significantly increased. The production of mutant batroxobin'also possessed coagulation activity.
出处 《蛇志》 2011年第2期105-110,共6页 Journal of Snake
关键词 突变巴曲酶 类凝血酶 巴斯德毕赤酵母 克隆和表达 偏好密码子 套叠PCR Mutant batroxobin Thrombin-like enzyme Pichia pastoris Cloning and expression Preferred codon Overlap extension of PCR
  • 相关文献

参考文献18

二级参考文献31

  • 1阎隆飞 孙之荣.蛋白质分子结构[M].北京:清华大学出版社,1998.. 被引量:1
  • 2萨姆布鲁克J 拉塞尔DW著 黄培堂译.分子克隆实验指南(第三版)[M].北京:科学出版社,2002.518-528. 被引量:39
  • 3张学敏,靶向新基因的分子克隆策略—理论与方法,1999年 被引量:1
  • 4阎隆飞,蛋白质分子结构,1998年 被引量:1
  • 5盛树力,多肽激素的当代理论和应用,1998年 被引量:1
  • 6Sleeman MW, Anderson KD, Lambert PD et al. The ciliary neurotrophic factor and its receptor, CNTFRα. Pharma Acta Helv, 2000,74(2) :265 - 272 被引量:1
  • 7Miller RG, Petajan JH, Bryan WW et al. A placedo-controlled trial of recombinant human ciliary neurotrophic factor (rhCNTF) in Amylotrophic Lateral Sclerosis. Ann Neurol, 1996,39(2):256-260 被引量:1
  • 8Lambert PD, Anderson KD, Sleeman MW et al. Ciliary neurotrophic factor activates leptin-like pathways and reduces body fat, without cachexia or rebound weight gain, even in leptin-resistant obesity. Proc Natl Acad Sci USA, 2001,98(8) :4652 -4657 被引量:1
  • 9Saggio I, Gloaguen I, Poiana G et al. CNTF variants with increased biological potency and receptor selectivity defined a function site of receptor interaction. The EMBO J, 1995,14(13) :3045 - 3054 被引量:1
  • 10Werten MWT, Bosch TTVD, Wind RD et al. High-yield secretion of recombinant gelatins by Pichia pastoris. Yeast, 1999,15(6): 1087 -1096 被引量:1

共引文献57

同被引文献39

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部